Skip to main content

Table 3 Multilevel modeling of psychobiological data

From: Characteristics of salivary cortisol and alpha-amylase as psychobiological study outcomes in palliative care research

Fixed effects

M1: sCort (covariates)

M2: sCort (+ treatment)

M3: sAA (covariates)

M4: sAA (+ treatment)

Est

p

Est

p

Est

p

Est

p

INTERCEPT

0.821

0.000

0.974

0.000

4.679

0.000

4.745

0.000

SEQUENCE (0 = MI—> CC, 1 = CC—> MI)

-0.106

0.639

-0.145

0.506

-0.124

0.669

-0.206

0.459

TIME (linear: 0, 1, 2, 3)

-0.033

0.013

-0.048

0.009

0.010

0.732

0.028

0.484

TREAT (0 = CC, 1 = MI)

-

-

-0.048

0.678

-

-

-0.037

0.799

SEX (0 = male, 1 = female)

-

-

-

-

-0.826

0.010

-0.761

0.015

MED.SEDA (0 = no, 1 = yes)

0.691

0.038

0.682

0.035

-

-

-

-

MED.CORT (0 = no, 1 = yes)

-0.920

0.030

-0.820

0.035

-

-

-

-

TIME SINCE LAST MEAL (minutes)

0.001

0.002

0.001

0.001

-

-

-

-

TIME*TREAT

-

-

0.032

0.214

-

-

-0.015

0.798

Random effects (variances)

  INTERCEPT L3 (across patients)

0.303

-

0.271

-

0.631

-

0.613

-

  INTERCEPT L2 (across sessions)

0.186

-

0.198

-

0.189

-

0.200

-

  Residual variance

0.057

-

0.059

-

0.331

-

0.334

-

Model fit

  AIC

244.104

-

271.232

-

728.881

-

771.726

-

  BIC

276.688

-

311.973

-

755.215

-

806.027

-

N

  Observations (L1)

276

-

300

-

318

-

334

-

  Sessions (L2)

69

-

75

-

80

-

84

-

  Patients (L3)

38

-

38

-

40

-

42

-

  1. Notes: sCort salivary cortisol (log-transformed), sAA salivary alpha-amylase (log-transformed), M model, L level, Est Estimate, MI mindfulness intervention, CC control condition, MED.SEDA sedative medication, MED.CORT corticosteroid medication, AIC Akaike Information Criterion, BIC Bayesian information criterion, bold effects were statistically significant on the level of p < 0.05